Impaired inhibitory processing: a new therapeutic target for autism and psychosis?
Scientific Abstract
In the healthy brain, homeostatic balance between excitation and inhibition maintains neural stability. Reduced inhibition may explain shared symptoms observed in autism and psychosis. Here we review evidence suggesting that altered levels of gamma-aminobutyric acid (GABA) may underlie both disorders, providing a potential cross-diagnostic therapeutic target.
Citation
2021. Br J Psychiatry, 218(6):295-298.
DOI
10.1192/bjp.2020.163
Free Full Text at Europe PMC
Related Content
Publication
2017.Proc. Natl. Acad. Sci. U.S.A., 114(26):6666-6674.
Publication
2024. Nat Metab, 6(11):2100-2117.
Publication
2017.Brain, 140(7):1977-1986.